Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T16:12:49.046Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:12:49.046Z.

Quote observation: 2026-10-06T15:53:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 23,964,823
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 50,644,000
TTM operating income · period ending 2026-06-30: -50,834,000

FMP input reference: 0b8025f704655349782d47d219081ed0d317ba91c4dcab760c02f1a4064a70a5

EV/EBITDA|EV/Sales|Operating Income|All Metrics

KYNB EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

EV/EBIT RATIO AVG TTM

N/A

EV/EBIT RATIO AVG 3Y

N/A

EV/EBIT RATIO AVG 5Y

N/A

EV/EBIT RATIO AVG 10Y

N/A

EV/EBIT RATIO AVG 15Y

N/A

EV/EBIT RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

KYNB Competitors' EV/EBIT Ratio

KYNB

Kyntra Bio, Inc.

Current

Market Cap

$23.96M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATOS

Atossa Therapeutics, Inc.

vs KYNB

Market Cap

$24.74M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABVC

ABVC BioPharma, Inc.

vs KYNB

Market Cap

$24.96M

EV/EBIT Ratio

N/A

TTM Avg

11456.84x

3Y Avg

11456.84x

5Y Avg

11456.84x

RNTX

Rein Therapeutics Inc.

vs KYNB

Market Cap

$22.75M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs KYNB

Market Cap

$22.65M

EV/EBIT Ratio

N/A

TTM Avg

21.00x

3Y Avg

21.00x

5Y Avg

21.00x

LONA

LeonaBio, Inc.

vs KYNB

Market Cap

$22.44M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ITOC

iTonic Holdings Ltd.

vs KYNB

Market Cap

$26.73M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSPR

InspireMD, Inc.

vs KYNB

Market Cap

$26.27M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MODD

Modular Medical, Inc.

vs KYNB

Market Cap

$20.38M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs KYNB

Market Cap

$20.54M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Kyntra Bio, Inc. (KYNB)	$23.96M	N/A	N/A	N/A	N/A
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.74M	N/A	N/A	N/A	N/A
ABVC BioPharma, Inc. (ABVC)vs ›	$24.96M	N/A	11456.84x	11456.84x	11456.84x
Rein Therapeutics Inc. (RNTX)vs ›	$22.75M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.65M	N/A	21.00x	21.00x	21.00x
LeonaBio, Inc. (LONA)vs ›	$22.44M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$26.73M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$26.27M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$20.38M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$20.54M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

KYNB EV/EBIT Ratio History

DATE	EV/EBIT RATIO
2020-03-02	116.36x
2020-02-28	112.57x
2020-02-27	109.10x
2020-02-26	111.65x
2020-02-25	115.83x
2020-02-24	117.59x
2020-02-21	122.89x
2020-02-20	122.44x
2020-02-19	123.51x
2020-02-18	121.04x
2020-02-14	123.17x
2020-02-13	120.17x
2020-02-12	122.55x
2020-02-11	120.51x
2020-02-10	117.48x
2020-02-07	116.69x
2020-02-06	123.20x
2020-02-05	124.23x
2020-02-04	123.76x
2020-02-03	116.97x
2020-01-31	112.71x
2020-01-30	113.92x
2020-01-29	113.25x
2020-01-28	112.94x
2020-01-27	112.04x
2020-01-24	112.57x
2020-01-23	119.19x
2020-01-22	117.93x
2020-01-21	115.77x
2020-01-17	119.72x
2020-01-16	120.39x
2020-01-15	114.48x
2020-01-14	115.32x
2020-01-13	112.52x
2020-01-10	113.27x
2020-01-09	114.56x
2020-01-08	115.40x
2020-01-07	115.01x
2020-01-06	116.92x
2020-01-03	116.19x
2020-01-02	118.35x
2019-12-31	115.63x
2019-12-30	117.09x
2019-12-27	121.24x
2019-12-26	126.42x
2019-12-24	123.90x
2019-12-23	121.32x
2019-12-20	122.38x
2019-12-19	125.58x
2019-12-18	125.05x
2019-12-17	128.52x
2019-12-16	128.38x
2019-12-13	126.28x
2019-12-12	128.94x
2019-12-11	127.99x
2019-12-10	130.12x
2019-12-09	129.28x
2019-12-06	128.24x
2019-12-05	127.54x
2019-12-04	126.53x
2019-12-03	119.41x
2019-12-02	118.74x
2019-11-29	114.17x
2019-11-27	109.29x
2019-11-26	107.58x
2019-11-25	108.45x
2019-11-22	103.16x
2019-11-21	101.56x
2019-11-20	101.33x
2019-11-19	100.94x
2019-11-18	98.76x
2019-11-15	99.09x
2019-11-14	93.46x
2019-11-13	92.34x
2019-11-12	78.90x
2019-11-11	78.54x
2019-11-08	92.41x
2019-11-07	84.27x
2019-11-06	85.05x
2019-11-05	88.73x
2019-11-04	82.13x
2019-11-01	88.84x
2019-10-31	86.90x
2019-10-30	87.04x
2019-10-29	87.28x
2019-10-28	90.38x
2019-10-25	87.97x
2019-10-24	88.78x
2019-10-23	86.19x
2019-10-22	87.93x
2019-10-21	87.10x
2019-10-18	86.12x
2019-10-17	89.94x
2019-10-16	89.47x
2019-10-15	86.26x
2019-10-14	84.41x
2019-10-11	82.76x
2019-10-10	81.33x
2019-10-09	81.17x
2019-10-08	80.66x
2019-10-07	81.86x
2019-10-04	81.57x
2019-10-03	80.39x
2019-10-02	78.43x
2019-10-01	80.46x
2019-09-30	82.06x
2019-09-27	83.89x
2019-09-26	83.82x
2019-09-25	84.79x
2019-09-24	84.50x
2019-09-23	90.67x
2019-09-20	88.58x
2019-09-19	88.02x
2019-09-18	90.94x
2019-09-17	91.95x
2019-09-16	92.86x
2019-09-13	92.12x
2019-09-12	94.49x
2019-09-11	96.45x
2019-09-10	91.70x
2019-09-09	90.00x
2019-09-06	92.55x
2019-09-05	93.40x
2019-09-04	92.17x
2019-09-03	92.50x
2019-08-30	99.19x
2019-08-29	101.74x
2019-08-28	100.64x
2019-08-27	97.14x
2019-08-26	99.51x
2019-08-23	92.64x
2019-08-22	96.67x
2019-08-21	99.66x
2019-08-20	99.08x
2019-08-19	100.89x
2019-08-16	99.06x
2019-08-15	95.80x
2019-08-14	96.27x
2019-08-13	100.15x
2019-08-12	100.27x
2019-08-09	102.63x

EV/EBIT Ratio: N/A

KYNB EV/EBIT Ratio Chart

KYNB EV/EBIT Ratio Metrics

KYNB Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

KYNB EV/EBIT Ratio History

Related Metrics